DMC Biotechnologies Series A funding round totals near $11.3 million

December 16, 2019 |

In Colorado, DMC Biotechnologies has completed additional closings as part of the Company’s Series A funding round which was led by Sofinnova Partners.  Boulder Ventures VII L.P. (BV) and SCG have now joined the Series A round bringing the total close to $11.3 million. Current investors Capricorn Partners and Breakthrough Energy Ventures also participated in the round.

DMC is preparing for the first commercial launch of its specialty amino acid product family in 2020 and is building a portfolio of biobased chemicals for commercialization.  

Print Friendly, PDF & Email

Tags: ,

Category: Fuels

Thank you for visting the Digest.